Nanotherapy could protect premature babies
Pre-clinical research in newborn rats found that a nanotherapy could prevent chronic lung disease in premature babies.
List view / Grid view
Stem cells are undifferentiated biological cells that can differentiate into specialised cells and can divide to produce more stem cells.
Pre-clinical research in newborn rats found that a nanotherapy could prevent chronic lung disease in premature babies.
Precision medicine in neurology is limited by a dearth of clinically relevant models. However, here Dr Evangelos Kiskinis, Assistant Professor at Northwestern University Feinberg School of Medicine, discusses how new technologies such as bioelectronic assays enable real-time, long-term analysis of neurological diseases in a dish, offering a pathway towards identifying…
Scientists have discovered the essential role of a ligand-dependent corepressor to potentially enable cancer cells to present tumour antigens on their surfaces.
A new study led by the Indiana University School of Medicine showed human induced pluripotent stem cells can improve visual acuity, vascular health and other complications related to type 2 diabetes.
New research by the Salk Institute has shown cellular rejuvenation therapy safely reverses signs of ageing in mice.
Scientists have gained deeper knowledge about the mislocalisation of a protein, providing a possible therapeutic target that could have implications in treating dementia.
An iPSC technology leader taps industry veteran to drive growth in cell therapy and drug discovery markets.
Long-awaited findings about cell differentiation will be relevant in understanding normal development and may also be useful in cancer research.
Researchers have successfully generated organoids in suspension, offering the possibility of larger-scale experiments to study human development and disease.
Researchers have innovated the petri dish to be able to grow and age live brain cells from patients with neurological disorders.
Researchers have identified potential age-related macular degeneration drugs using a novel stem-cell based research tool.
New research has shown that one-time infusion of stem cells from bone marrow improves the survival of mice with sepsis.
Researchers have made a respiratory model of COVID-19, made from patient-derived stem cells, to understand how the virus affects respiration and which could be used to test possible drugs.
The first patient-derived stem cell model to research eye conditions related to oculocutaneous albinism (OCA) has been created.
Scientists in Japan have developed a credible heart cell model for arrhythmogenic cardiomyopathy and observed a positive response in the condition using PKP2 gene therapy.